VIMKUNYA (chikungunya vaccine, recombinant/PF)
CHIKUNGUNYA VACCINE · CHIKUNGUNYA VIRUS VACCINATION
Nordic
Drug class
chikungunya vaccine
A chikungunya vaccine is an active immunizing biologic designed to stimulate the immune system to prevent disease caused by the chikungunya virus. Read more about chikungunya vaccine
1 drugs in this class 1 manufacturers
Drugs in chikungunya vaccine
Filter & compare in the drug finder →
Opens the drug finder with chikungunya vaccine preselected. Add indication or manufacturer filters there.
A chikungunya vaccine is an active immunizing biologic designed to stimulate the immune system to prevent disease caused by the chikungunya virus.
Formulated as live-attenuated or recombinant virus-like particle preparations, these vaccines work by eliciting neutralizing antibodies and protective immune responses against the mosquito-borne alphavirus.
Their therapeutic role is active prophylaxis against chikungunya virus infection and its associated manifestations, including acute febrile illness, rash, and debilitating acute or chronic polyarthralgia.
-
fda.gov
A chikungunya vaccine is an active immunizing biologic designed to stimulate the immune system to prevent disease caused by the chikungunya virus Formulated as live-attenuated or recombinant virus-like particle preparations, these vaccines work by eliciting neutralizing antibodies and protective immune responses against the mosquito-borne alphavirus
-
fda.gov
A chikungunya vaccine is an active immunizing biologic designed to stimulate the immune system to prevent disease caused by the chikungunya virus Their therapeutic role is active prophylaxis against chikungunya virus infection and its associated manifestations, including acute febrile illness, rash, and debilitating acute or chronic polyarthralgia
-
fda.gov
Formulated as live-attenuated or recombinant virus-like particle preparations, these vaccines work by eliciting neutralizing antibodies and protective immune responses against the mosquito-borne alphavirus
-
cdc.gov
Formulated as live-attenuated or recombinant virus-like particle preparations, these vaccines work by eliciting neutralizing antibodies and protective immune responses against the mosquito-borne alphavirus
-
cdc.gov
Their therapeutic role is active prophylaxis against chikungunya virus infection and its associated manifestations, including acute febrile illness, rash, and debilitating acute or chronic polyarthralgia
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.